| 2016 comprehensive update of the Banff working group on liver allograft pathology: introduction of antibody-mediated rejection AJ Demetris, C Bellamy, SG Hübscher, J O’leary, PS Randhawa, S Feng, ... American Journal of Transplantation 16 (10), 2816-2835, 2016 | 534 | 2016 |
| Five hundred intestinal and multivisceral transplantations at a single center: major advances with new challenges KM Abu-Elmagd, G Costa, GJ Bond, K Soltys, R Sindhi, T Wu, DA Koritsky, ... Annals of surgery 250 (4), 567-581, 2009 | 456 | 2009 |
| Clinical intestinal transplantation: a decade of experience at a single center K Abu-Elmagd, J Reyes, G Bond, G Mazariegos, T Wu, N Murase, ... Annals of surgery 234 (3), 404-417, 2001 | 428 | 2001 |
| Cyclooxygenase–2 Promotes Hepatocellular Carcinoma Cell Growth Through Akt Activation: Evidence for Akt Inhibition in Celecoxib–Induced Apoptosis J Leng, C Han, JA Demetris, GK Michalopoulos, T Wu Hepatology 38 (3), 756-768, 2003 | 395 | 2003 |
| Omega-3 polyunsaturated fatty acids inhibit hepatocellular carcinoma cell growth through blocking β-catenin and cyclooxygenase-2 K Lim, C Han, Y Dai, M Shen, T Wu Molecular cancer therapeutics 8 (11), 3046-3055, 2009 | 245 | 2009 |
| A schema for histologic grading of small intestine allograft acute rejection T Wu, K Abu-Elmagd, G Bond, MA Nalesnik, P Randhawa, AJ Demetris Transplantation 75 (8), 1241-1248, 2003 | 231 | 2003 |
| Docosahexaenoic acid induces autophagy through p53/AMPK/mTOR signaling and promotes apoptosis in human cancer cells harboring wild-type p53 K Jing, KS Song, S Shin, N Kim, S Jeong, HR Oh, JH Park, KS Seo, ... Autophagy 7 (11), 1348-1358, 2011 | 225 | 2011 |
| MicroRNA-26a promotes cholangiocarcinoma growth by activating β-catenin J Zhang, C Han, T Wu Gastroenterology 143 (1), 246-256. e8, 2012 | 208 | 2012 |
| Cyclooxygenase-2 promotes human cholangiocarcinoma growth: evidence for cyclooxygenase-2-independent mechanism in celecoxib-mediated induction of p21waf1/cip1 and p27kip1 and … C Han, J Leng, AJ Demetris, T Wu Cancer research 64 (4), 1369-1376, 2004 | 206 | 2004 |
| The cyclooxygenase-2 inhibitor celecoxib blocks phosphorylation of Akt and induces apoptosis in human cholangiocarcinoma cells T Wu, J Leng, C Han, AJ Demetris Molecular cancer therapeutics 3 (3), 299-307, 2004 | 190 | 2004 |
| Hedgehog signaling pathway regulates autophagy in human hepatocellular carcinoma cells Y Wang, C Han, L Lu, S Magliato, T Wu Hepatology 58 (3), 995-1010, 2013 | 188 | 2013 |
| Prostaglandin E2 receptor EP1 transactivates EGFR/MET receptor tyrosine kinases and enhances invasiveness in human hepatocellular carcinoma cells C Han, GK Michalopoulos, T Wu Journal of cellular physiology 207 (1), 261-270, 2006 | 187 | 2006 |
| The omega‐3 polyunsaturated fatty acid DHA induces simultaneous apoptosis and autophagy via mitochondrial ROS‐mediated Akt‐mTOR signaling in prostate cancer cells expressing … S Shin, K Jing, S Jeong, N Kim, KS Song, JY Heo, JH Park, KS Seo, J Han, ... BioMed research international 2013 (1), 568671, 2013 | 185 | 2013 |
| Cyclooxygenase-2-derived prostaglandin E2 promotes human cholangiocarcinoma cell growth and invasion through EP1 receptor-mediated activation of the epidermal growth factor … C Han, T Wu Journal of Biological Chemistry 280 (25), 24053-24063, 2005 | 181 | 2005 |
| Cyclooxygenase-2 in hepatocellular carcinoma T Wu Cancer Treatment Reviews 32 (1), 28-44, 2006 | 156 | 2006 |
| Airway inflammation JH Shelhamer, SJ Levine, T Wu, DB Jacoby, MA Kaliner, SI Rennard Annals of internal medicine 123 (4), 288-304, 1995 | 155 | 1995 |
| Cyclooxygenase-2–derived prostaglandin E2 activates β-catenin in human cholangiocarcinoma cells: evidence for inhibition of these signaling pathways by ω3 polyunsaturated fatty … K Lim, C Han, L Xu, K Isse, AJ Demetris, T Wu Cancer research 68 (2), 553-560, 2008 | 146 | 2008 |
| P11, a unique member of the S100 family of calcium-binding proteins, interacts with and inhibits the activity of the 85-kDa cytosolic phospholipase A2 T Wu, CW Angus, XL Yao, C Logun, JH Shelhamer Journal of Biological Chemistry 272 (27), 17145-17153, 1997 | 146 | 1997 |
| Evolution of the immunosuppressive strategies for the intestinal and multivisceral recipients with special reference to allograft immunity and achievement of partial tolerance KM Abu‐Elmagd, G Costa, GJ Bond, T Wu, N Murase, A Zeevi, ... Transplant International 22 (1), 96-109, 2009 | 139 | 2009 |
| Epigenetic regulation of MicroRNA‐122 by peroxisome proliferator activated receptor‐gamma and hepatitis b virus X protein in hepatocellular carcinoma cells K Song, C Han, J Zhang, D Lu, S Dash, M Feitelson, K Lim, T Wu Hepatology 58 (5), 1681-1692, 2013 | 130 | 2013 |
